Hospira has been putting patients first for more than 80 years. We are committed to continuing to make the investments and take the actions necessary to ensure we’re the strongest partner possible for our customers and patients. Although we and our industry have faced some tough challenges over the past few years, we’ve committed our time, people and more than $1 billion to improve our facilities and enhance our ability to deliver the high-quality products that patients need in the quantities they need them. Additionally, we’re increasing our research and development funding – pioneering groundbreaking I.V. clinical integration technology for hospitals and working to offer life-impacting biosimilar treatments to patients around the globe.
In his latest video, CEO Mike Ball details the company’s commitment to investing more than $1 billion to better serve the customers and patients that depend on us today and also ensure that our central role in the healthcare system remains vibrant in the future.
Hospira is investing more than $1 billion to enhance current operations, increase manufacturing capacity and better serve our customers. Learn more about the improvements and investments that the company is making today for an even stronger tomorrow.
CEO Mike Ball’s ongoing video series highlights Hospira’s comprehensive efforts to do what is right for customers and patients.